IGF1R and Hyperglycemia: While Remo did not affect overall body weight (Supplement Figure 2(A)) or adipose tissue loss due to IR/IGF1R knockout (Figure 2(A)), Remo treatment did prevent the development of random fed and fasting hyperglycemia in the Ai-DKO mice (Figure 2(B) and (C)).